Adult polyglucosan body disease, often shortened to APBD, is a rare inherited condition of the nervous system. Signs usually first appear between the ages of 35 and 60, beginning with numbness and tingling in the legs from peripheral neuropathy and with progressive muscle weakness and stiffness, so that people walk unsteadily, lose balance and fall more easily. Damage to the nerves that control the bladder, called neurogenic bladder, often appears early and makes it hard to start or stop the flow of urine. Over time most people lose control of the bladder, the bowels and the limbs, and damage to the autonomic nervous system disturbs blood pressure, heart rate, breathing, digestion, temperature regulation and sexual response and brings daily bouts of exhaustion. About half of those affected develop dementia. Mutations in the GBE1 gene, which makes the glycogen branching enzyme, usually cause the disease, and abnormal glycogen called polyglucosan bodies builds up in nerve cells; the inheritance is autosomal recessive. Roughly 200 people had been diagnosed worldwide, and researchers suspect the disorder is underdiagnosed.
Facts
Classification
ICD-10 ChapterIV: Endocrine, Nutritional and Metabolic Diseases 2 Communicable or Non-communicable Transmission Route Causative Agent
Causative Agent (category) First Described Connections
Treated By
Source National Organization for Rare Disorders (NORD): Adult polyglucosan body disease (NORD Rare Disease Database)
Source National Organization for Rare Disorders (NORD): Adult polyglucosan body disease (NORD Rare Disease Database)
Sources
1. Adult polyglucosan body disease (MedlinePlus Genetics)
Description, first sentence
Adult polyglucosan body disease (APBD) is a condition that affects the nervous system.
Causes
Mutations in the GBE1 gene cause APBD.
Inheritance
This condition is inherited in an autosomal recessive pattern
View the Source2. EMBL-EBI Ontology Lookup Service (Orphanet ontology): Adult polyglucosan body disease (Orphanet term in EMBL-EBI OLS4)
EMBL-EBI Ontology Lookup Service (Orphanet ontology)cross reference, ICD-10 code; chapter derived from the codeQuote, cross reference, ICD-10 code; chapter derived from the code
ICD-10:E74.0
View the Source 3. National Organization for Rare Disorders (NORD): Adult polyglucosan body disease (NORD Rare Disease Database)
National Organization for Rare Disorders (NORD)sentence that gives the year the condition was first described
APBD was first described in the medical literature as a clinical entity in 1980 (Robitaille Y et. al).
Treated By: Physical Therapy, Standard Therapies
Physical and occupational therapy is of benefit for some affected individuals.
Treated By: Occupational Therapy, Standard Therapies
Physical and occupational therapy is of benefit for some affected individuals.
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.